1. Home
  2. BDTX vs TAYD Comparison

BDTX vs TAYD Comparison

Compare BDTX & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • TAYD
  • Stock Information
  • Founded
  • BDTX 2014
  • TAYD 1955
  • Country
  • BDTX United States
  • TAYD United States
  • Employees
  • BDTX N/A
  • TAYD N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • TAYD Industrial Machinery/Components
  • Sector
  • BDTX Health Care
  • TAYD Industrials
  • Exchange
  • BDTX Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • BDTX 132.5M
  • TAYD 114.6M
  • IPO Year
  • BDTX 2020
  • TAYD N/A
  • Fundamental
  • Price
  • BDTX $2.41
  • TAYD $43.24
  • Analyst Decision
  • BDTX Strong Buy
  • TAYD
  • Analyst Count
  • BDTX 5
  • TAYD 0
  • Target Price
  • BDTX $15.60
  • TAYD N/A
  • AVG Volume (30 Days)
  • BDTX 1.4M
  • TAYD 34.6K
  • Earning Date
  • BDTX 08-05-2025
  • TAYD 08-14-2025
  • Dividend Yield
  • BDTX N/A
  • TAYD N/A
  • EPS Growth
  • BDTX N/A
  • TAYD 1.48
  • EPS
  • BDTX 0.09
  • TAYD 2.50
  • Revenue
  • BDTX $70,000,000.00
  • TAYD $42,796,782.00
  • Revenue This Year
  • BDTX N/A
  • TAYD $15.06
  • Revenue Next Year
  • BDTX N/A
  • TAYD $8.37
  • P/E Ratio
  • BDTX $27.30
  • TAYD $17.61
  • Revenue Growth
  • BDTX N/A
  • TAYD N/A
  • 52 Week Low
  • BDTX $1.20
  • TAYD $29.50
  • 52 Week High
  • BDTX $6.75
  • TAYD $64.50
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 57.88
  • TAYD 76.09
  • Support Level
  • BDTX $2.15
  • TAYD $36.41
  • Resistance Level
  • BDTX $2.71
  • TAYD $36.71
  • Average True Range (ATR)
  • BDTX 0.17
  • TAYD 1.97
  • MACD
  • BDTX -0.01
  • TAYD 0.89
  • Stochastic Oscillator
  • BDTX 55.36
  • TAYD 99.80

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: